Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO).

PubWeight™: 2.12‹?› | Rank: Top 2%

🔗 View Article (PMID 15961712)

Published in Stroke on June 16, 2005

Authors

Anne W Wojner-Alexandrov1, Andrei V Alexandrov, Diana Rodriguez, David Persse, James C Grotta

Author Affiliations

1: Department of Neurology, University of Texas-Houston, Houston, TX 77030, USA. anne.wojner@health-outcomes-institute.com

Articles citing this

Prehospital stroke scales in urban environments: a systematic review. Neurology (2014) 2.32

Optimization modeling to maximize population access to comprehensive stroke centers. Neurology (2015) 1.42

Systematic review of mass media interventions designed to improve public recognition of stroke symptoms, emergency response and early treatment. BMC Public Health (2010) 1.40

Early identification and delay to treatment in myocardial infarction and stroke: differences and similarities. Scand J Trauma Resusc Emerg Med (2010) 1.01

Disparities in accessibility of certified primary stroke centers. Stroke (2014) 0.93

Provision of acute stroke care and associated factors in a multiethnic population: prospective study with the South London Stroke Register. BMJ (2011) 0.93

Translation of the 'time is brain' concept into clinical practice: focus on prehospital stroke management. Int J Stroke (2014) 0.92

An emergency clinical pathway for stroke patients--results of a cluster randomised trial (isrctn41456865). BMC Health Serv Res (2009) 0.88

Influence of direct admission to Comprehensive Stroke Centers on the outcome of acute stroke patients treated with intravenous thrombolysis. J Neurol (2009) 0.88

Intravenous rt-PA: a tenth anniversary reflection. Surg Neurol (2007) 0.86

The Massachusetts Emergency Medical Service Stroke Quality Improvement Collaborative, 2009-2012. Prev Chronic Dis (2013) 0.84

Stroke warning campaigns: delivering better patient outcomes? A systematic review. Patient Relat Outcome Meas (2015) 0.84

Impact of Telemedicine on Access to Acute Stroke Care in the State of Texas. Ann Clin Transl Neurol (2014) 0.83

An evaluation of emergency medical services stroke protocols and scene times. Prehosp Emerg Care (2013) 0.82

Prehospital utility of rapid stroke evaluation using in-ambulance telemedicine: a pilot feasibility study. Stroke (2014) 0.82

Routing Ambulances to Designated Centers Increases Access to Stroke Center Care and Enrollment in Prehospital Research. Stroke (2015) 0.82

The effects of telemedicine on racial and ethnic disparities in access to acute stroke care. J Telemed Telecare (2015) 0.81

The economics of treating stroke as an acute brain attack. BMC Med (2009) 0.80

[Implementation of thrombolysis in acute stroke--10-year results of the Innsbruck stroke registry]. Wien Klin Wochenschr (2009) 0.78

[Avoiding time delay in acute stroke management. Data analysis of the Austrian Stroke Unit Registry]. Wien Med Wochenschr (2008) 0.78

Nursing Roles within a Stroke Telemedicine Network. J Cent Nerv Syst Dis (2010) 0.78

Training emergency services' dispatchers to recognise stroke: an interrupted time-series analysis. BMC Health Serv Res (2013) 0.77

Multilevel educational program for emergency medical services. Stroke (2005) 0.75

Race and sex disparities in prehospital recognition of acute stroke. Acad Emerg Med (2015) 0.75

A pathway care model allowing low-risk patients to gain direct admission to a hospital medical ward--a pilot study on ambulance nurses and Emergency Department physicians. Scand J Trauma Resusc Emerg Med (2014) 0.75

Primary stroke center concept: strengths and limitations. Front Neurol (2012) 0.75

The Effect of Telemedicine on Access to Acute Stroke Care in Texas: The Story of Age Inequalities. Stroke Res Treat (2015) 0.75

Sex Disparities in Access to Acute Stroke Care: Can Telemedicine Mitigate this Effect? J Health Dispar Res Pract (2016) 0.75

Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest. Biosensors (Basel) (2017) 0.75

Dispatch and prehospital transport for acute septic patients: an observational study. Scand J Trauma Resusc Emerg Med (2017) 0.75

Articles by these authors

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92

Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21

Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med (2004) 5.32

Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. Radiology (2003) 3.59

Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey. Lancet (2008) 3.30

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet (2006) 2.97

Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke (2007) 2.93

Dominant form of vanishing white matter-like leukoencephalopathy. Ann Neurol (2005) 2.67

Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet (2009) 2.50

Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results. Stroke (2010) 2.29

NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1. J Invest Dermatol (2010) 2.25

Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology (2002) 2.18

Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology (2005) 2.06

Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol (2007) 2.05

Guidelines for screening of extracranial carotid artery disease: a statement for healthcare professionals from the multidisciplinary practice guidelines committee of the American Society of Neuroimaging; cosponsored by the Society of Vascular and Interventional Neurology. J Neuroimaging (2007) 2.05

Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke (2002) 1.97

Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene. J Neurol Neurosurg Psychiatry (2012) 1.94

Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke (2012) 1.91

Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res (2010) 1.89

Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain (2003) 1.85

Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab (2009) 1.80

Anticoagulation after cardioembolic stroke: to bridge or not to bridge? Arch Neurol (2008) 1.79

Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75

The IVH score: a novel tool for estimating intraventricular hemorrhage volume: clinical and research implications. Crit Care Med (2009) 1.73

Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke (2006) 1.70

Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial. J Neuroimaging (2004) 1.69

The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke (2012) 1.68

Acute stroke imaging research roadmap. Stroke (2008) 1.66

Changes in spleen size in patients with acute ischemic stroke: a pilot observational study. Int J Stroke (2012) 1.66

Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol (2011) 1.64

LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis (2008) 1.62

Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. Stroke (2002) 1.62

Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke (2003) 1.61

Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke (2007) 1.61

Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke (2004) 1.59

Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke. Arch Neurol (2008) 1.59

Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke. Circulation (2007) 1.58

Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol (2009) 1.52

Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke (2009) 1.52

Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke (2004) 1.50

Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med (2003) 1.48

Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47

NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat (2010) 1.47

A prospective, multicenter pilot study to evaluate the feasibility and safety of using the CoolGard System and Icy catheter following cardiac arrest. Resuscitation (2004) 1.46

The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med (2005) 1.44

The effect of activated factor VII for intracerebral hemorrhage beyond 3 hours versus within 3 hours. Stroke (2008) 1.43

Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable. Stroke (2005) 1.42

A randomized, controlled trial to teach middle school children to recognize stroke and call 911: the kids identifying and defeating stroke project. Stroke (2007) 1.42

Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series. Stroke (2011) 1.42

Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet (2003) 1.41

Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. J Neurosci (2009) 1.41

Diagnostic criteria and yield of real-time transcranial Doppler monitoring of intra-arterial reperfusion procedures. Stroke (2010) 1.41

Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41

Thrombolysis in stroke despite contraindications or warnings? Stroke (2013) 1.40

Can comprehensive stroke centers erase the 'weekend effect'? Cerebrovasc Dis (2008) 1.39

Feasibility of carotid artery stenting in patients with angiographic string sign. Catheter Cardiovasc Interv (2010) 1.39

Cell death in experimental intracerebral hemorrhage: the "black hole" model of hemorrhagic damage. Ann Neurol (2002) 1.39

Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet (2011) 1.38

Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci (2009) 1.38

New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology (2012) 1.35

Constraint-induced movement therapy during early stroke rehabilitation. Neurorehabil Neural Repair (2006) 1.34

Argatroban tPA stroke study: study design and results in the first treated cohort. Arch Neurol (2006) 1.33

A spectrum of knock-type Doppler signals in the intracranial vessels. Stroke (2008) 1.31

The spot sign in intracerebral hemorrhage: the importance of looking for contrast extravasation. Cerebrovasc Dis (2009) 1.30

Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics (2003) 1.30

A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke. Stroke (2008) 1.30

Reversed Robin Hood syndrome in acute ischemic stroke patients. Stroke (2007) 1.26

15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. J Cereb Blood Flow Metab (2006) 1.26

IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res (2010) 1.24

Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res (2011) 1.24

Thrombolytic therapy for patients who wake-up with stroke. Stroke (2009) 1.23

Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging (2002) 1.23

Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke (2010) 1.22

X-linked lissencephaly with absent corpus callosum and ambiguous genitalia (XLAG): clinical, magnetic resonance imaging, and neuropathological findings. Ann Neurol (2002) 1.22

RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection. Nat Genet (2009) 1.22

Intravenous TPA for very old stroke patients. Eur Neurol (2005) 1.21

Intracerebral hemorrhage in cocaine users. Stroke (2010) 1.20

Carotid ultrasonography for detection of vascular abnormalities in hypertensive children. Pediatr Nephrol (2003) 1.20

AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke (2010) 1.19

Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A (2015) 1.17

Distinct patterns of intracerebral hemorrhage-induced alterations in NF-kappaB subunit, iNOS, and COX-2 expression. J Neurochem (2007) 1.16

Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke (2003) 1.16

Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France. Orphanet J Rare Dis (2011) 1.16

A case-crossover analysis of out-of-hospital cardiac arrest and air pollution. Circulation (2013) 1.16

Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke (2009) 1.15

Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke. J Neurosci Res (2010) 1.15

The role of sonolysis and sonothrombolysis in acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials and case-control studies. J Neuroimaging (2013) 1.14

Hypothermia for acute ischaemic stroke. Lancet Neurol (2013) 1.13

Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. Eur J Hum Genet (2004) 1.11